Vogelmeier C - Search Results

1

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Vestbo J, et al. Among authors: vogelmeier c. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. Am J Respir Crit Care Med. 2013. PMID: 22878278 Review.

2

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.

Behr J, Vogelmeier C, Beinert T, Meurer M, Krombach F, König G, Fruhmann G. Behr J, et al. Among authors: vogelmeier c. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):400-6. doi: 10.1164/ajrccm.154.2.8756813. Am J Respir Crit Care Med. 1996. PMID: 8756813

3

[Chronic obstructive lung disease].

Vogelmeier C. Vogelmeier C. Internist (Berl). 2003 Jun;44 Suppl 1:S16-22, S24-7. doi: 10.1007/s00108-003-0930-8. Internist (Berl). 2003. PMID: 14567085 Review. German.

4

Automatic CPAP titration with different self-setting devices in patients with obstructive sleep apnoea.

Stammnitz A, Jerrentrup A, Penzel T, Peter JH, Vogelmeier C, Becker HF. Stammnitz A, et al. Among authors: vogelmeier c. Eur Respir J. 2004 Aug;24(2):273-8. doi: 10.1183/09031936.04.00074304. Eur Respir J. 2004. PMID: 15332397 Clinical Trial.

5

TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease.

Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Müller B, Vogelmeier C, von Wichert P. Seifart C, et al. Among authors: vogelmeier c. Tissue Antigens. 2005 Jan;65(1):93-100. doi: 10.1111/j.1399-0039.2005.00343.x. Tissue Antigens. 2005. PMID: 15663746

6

[Bronchodilators in chronic obstructive pulmonary disease (COPD)].

Gillissen A, Buhl R, Rabe KF, Vogelmeier C, Welte T. Gillissen A, et al. Among authors: vogelmeier c. Med Klin (Munich). 2005 May 13;100(5):246-54. doi: 10.1007/s00063-005-1031-3. Med Klin (Munich). 2005. PMID: 15902378 Review. German.

7

Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling.

Haughney J, Partridge MR, Vogelmeier C, Larsson T, Kessler R, Ståhl E, Brice R, Löfdahl CG. Haughney J, et al. Among authors: vogelmeier c. Eur Respir J. 2005 Oct;26(4):623-9. doi: 10.1183/09031936.05.00142704. Eur Respir J. 2005. PMID: 16204592

8

[Pathogenesis of chronic obstructive pulmonary disease].

Vogelmeier C, Koczulla R, Fehrenbach H, Bals R. Vogelmeier C, et al. Internist (Berl). 2006 Sep;47(9):885-6, 888-90, 892-4. doi: 10.1007/s00108-006-1691-y. Internist (Berl). 2006. PMID: 16845536 Review. German.

9

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Kardos P, Wencker M, Glaab T, Vogelmeier C. Kardos P, et al. Among authors: vogelmeier c. Am J Respir Crit Care Med. 2007 Jan 15;175(2):144-9. doi: 10.1164/rccm.200602-244OC. Epub 2006 Oct 19. Am J Respir Crit Care Med. 2007. PMID: 17053207 Clinical Trial.

10

Chronic obstructive pulmonary disease and premature aging.

Vogelmeier C, Bals R. Vogelmeier C, et al. Am J Respir Crit Care Med. 2007 Jun 15;175(12):1217-8. doi: 10.1164/rccm.200703-513ED. Am J Respir Crit Care Med. 2007. PMID: 17545454 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results